
Bloomberg Surveillance: Tax Bill and Markets
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Calumet Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Explore Calumet's Fair Values from the Community and select yours Calumet (NASDAQ:CLMT) Second Quarter 2025 Results Key Financial Results Revenue: US$1.03b (down 9.4% from 2Q 2024). Net loss: US$147.9m (loss widened by 271% from 2Q 2024). US$1.70 loss per share (further deteriorated from US$0.49 loss in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Calumet Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 8.3%. Earnings per share (EPS) missed analyst estimates significantly. Looking ahead, revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Oil and Gas industry in the US. Performance of the American Oil and Gas industry. The company's shares are down 7.4% from a week ago. Risk Analysis We should say that we've discovered 3 warning signs for Calumet (2 don't sit too well with us!) that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
2 minutes ago
- Yahoo
Emera Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Explore Emera's Fair Values from the Community and select yours Emera (TSE:EMA) Second Quarter 2025 Results Key Financial Results Revenue: CA$1.99b (up 23% from 2Q 2024). Net income: CA$154.0m (up 19% from 2Q 2024). Profit margin: 7.7% (down from 8.0% in 2Q 2024). The decrease in margin was driven by higher expenses. EPS: CA$0.52 (up from CA$0.45 in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Emera Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 9.7%. Earnings per share (EPS) missed analyst estimates by 30%. Looking ahead, revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Electric Utilities industry in North America. Performance of the market in Canada. The company's shares are up 3.7% from a week ago. Risk Analysis Before you take the next step you should know about the 2 warning signs for Emera that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 minutes ago
- Yahoo
Spectral Medical Second Quarter 2025 Earnings: CA$0.007 loss per share (vs CA$0.016 loss in 2Q 2024)
Explore Spectral Medical's Fair Values from the Community and select yours Spectral Medical (TSE:EDT) Second Quarter 2025 Results Key Financial Results Revenue: CA$813.0k (up 73% from 2Q 2024). Net loss: CA$1.93m (loss narrowed by 56% from 2Q 2024). CA$0.007 loss per share (improved from CA$0.016 loss in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Spectral Medical Earnings Insights Looking ahead, revenue is forecast to grow 72% p.a. on average during the next 3 years, compared to a 66% growth forecast for the Biotechs industry in Canada. Performance of the Canadian Biotechs industry. The company's shares are down 1.2% from a week ago. Risk Analysis Be aware that Spectral Medical is showing 4 warning signs in our investment analysis and 3 of those are significant... Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.